PG
IBB icon

PEAK6 Group’s iShares Biotechnology ETF IBB Stock Holding History

PEAK6 Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$9.96M Buy
90,700
+15,000
+20% +$1.6M 0.04% 446
2018
Q1 		$8.08M Sell
75,700
-8,300
-10% -$920K 0.04% 555
2017
Q4 		$8.97M Sell
84,000
-22,500
-21% -$2.41M 0.04% 527
2017
Q3 		$11.8M Buy
106,500
+16,500
+18% +$1.76M 0.06% 345
2017
Q2 		$9.3M Sell
90,000
-88,500
-50% -$8.72M 0.05% 409
2017
Q1 		$17.4M Buy
178,500
+57,300
+47% +$5.49M 0.14% 151
2016
Q4 		$10.7M Buy
121,200
+51,900
+75% +$4.72M 0.08% 334
2016
Q3 		$6.69M Sell
69,300
-297,000
-81% -$28.3M 0.05% 531
2016
Q2 		$31.4M Buy
366,300
+261,000
+248% +$23.4M 0.24% 50
2016
Q1 		$9.15M Buy
105,300
+29,400
+39% +$2.63M 0.07% 354
2015
Q4 		$8.56M Sell
75,900
-30,000
-28% -$3.26M 0.06% 439
2015
Q3 		$10.7M Buy
105,900
+52,800
+99% +$6.33M 0.06% 440
2015
Q2 		$6.53M Sell
53,100
-13,500
-20% -$1.62M 0.04% 669
2015
Q1 		$7.62M Buy
66,600
+21,900
+49% +$2.42M 0.06% 447
2014
Q4 		$4.52M Buy
+44,700
New +$4.34M 0.03% 741
2014
Q3 		– Sell
-2,700
Closed -$231K – 4882
2014
Q2 		$231K Sell
2,700
-61,200
-96% -$4.82M ﹤0.01% 3075
2014
Q1 		$5.04M Buy
+63,900
New +$5.32M 0.04% 627
2013
Q3 		– Sell
-15,000
Closed -$869 – 5272
2013
Q2 		$869 Buy
+15,000
New +$867K ﹤0.01% 2261

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

PEAK6 Group's IBB Position: Q2 2018 in Review

PEAK6 Group opened a new position in iShares Biotechnology ETF (IBB) in Q2 2018: 34,807 shares worth $3.82M. The stake represents 0.02% of the portfolio and ranks #923 among its holdings. This is a return to the name: PEAK6 Group previously reported a position in IBB as recently as Q4 2017.

PEAK6 Group first reported a position in IBB in Q2 2014 and has held it in 14 quarters since. The position peaked at $13.7M in Q4 2017. 609 funds tracked by Wall St. Rank hold IBB as of Q2 2018.

  • PEAK6 Group held 34,807 shares of iShares Biotechnology ETF worth $3.82M as of Q2 2018.
  • iShares Biotechnology ETF was a new PEAK6 Group position in Q2 2018.
  • iShares Biotechnology ETF made up 0.02% of PEAK6 Group's portfolio in Q2 2018, its #923 holding.
  • PEAK6 Group first reported a position in iShares Biotechnology ETF in Q2 2014 and has held it in 14 quarters since.
  • PEAK6 Group's iShares Biotechnology ETF position peaked at $13.7M in Q4 2017.
  • 609 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.